期刊文献+

2型糖尿病患者血浆PAI-1水平与尿微量白蛋白的相关性研究 被引量:1

Relations of the level of plasma PAI-1 with urine micro-albumin in type 2 diabetes mellitus
原文传递
导出
摘要 目的探讨2型糖尿病(T2DM)患者血浆PAI-1水平变化及其与尿微量白蛋白(MAU)的相关性,了解PAI-1在2型糖尿病及其血管并发症发病机制中的作用。方法选取60例未经过治疗的初诊T2DM患者(观察组)和30例与T2DM患者临床资料相匹配的正常健康体检者(对照组)为研究对象,并根据MAU检测结果将观察组分为MAU正常亚组(30例)和MAU阳性亚组(30例),按标准方法检测研究对象的血糖(FBG)、胰岛素(FINS)、糖化血红蛋白(HbA1c)、血脂(TC、TG、LDL-C和HDL-C)、血浆PAI-1、MAU等,并应用SPSS11.0统计软件对检测结果进行相应的统计学分析。结果 (1)观察组FBG、HbA1c、TC、TG、LDL-C水平显著高于对照组(P<0.01或P<0.05),但两组HDL-C水平无显著差异(P>0.05),而且观察组两亚组间各指标差异均无统计学意义(P>0.05)。(2)MAU正常亚组FINS水平与对照组差异无统计学意义(P>0.05),但MAU阳性亚组FINS水平显著高于对照组(P<0.05),且观察组两亚组间差异无统计学意义(P>0.05)。(3)观察组HOMA-IR水平显著高于对照组(P<0.05),但观察组两亚组之间差异无统计学意义(P>0.05)。(4)观察组两个亚组血浆PAI-1水平均显著高于对照组(P<0.01),而且MAU阳性亚组血浆PAI-1水平亦显著高于MAU正常亚组(P<0.01)。(5)血浆PAI-1水平与Alb/cr、HOMA-IR、FBG、HbA1c、BMI、TC、TG等指标水平均呈正直线相关(P<0.01或P<0.05);多元逐步回归分析显示Alb/cr、HbA1c水平为影响空腹血浆PAI-1水平的显著因素,其中HbA1c可以解释空腹血浆PAI-1浓度变化的49.3%、Alb/cr可以解释空腹血浆PAI-1浓度变化的28.9%(校正的R2值分别为0.493、0.782,P均<0.01)。结论 (1)T2DM患者血浆PAI-1水平升高,而且伴有MAU阳性的患者血浆PAI-1水平升高更为明显。(2)血浆PAI-1水平与MAU水平呈正直线相关,表明PAI-1可能是糖尿病血管并发症发生的一个危险因素。 Objective To evaluate the relevance of plasma PAI-1 levels and MAU in patients with type 2 diabetes mellitus,to understand the role of PAI-1 in in the pathogenesis of type 2 diabetes mellitus and its vascular complications. Methods Selected 60 cases of newly diagnosed T2DM patients without treatment(experimental group)and 30 health cases(control group)as the research object,according to the results of MAU the(experimental group were divided into MAU normal group (n = 30)and MAU positive group (30 cases), detection the result of FBG, FINS, HbAlc,blood lipid(TC,TG,LDL-C and HDL-C) ,plasma PAI-1 ,MAU et,make the corresponding statistical analysis. With the SPSSll. 0 to test results. Results (1)The experimental group FBG, HbAlc,TC,TG,LDL-C was significantly higher than that of control group(P〈0. 01 or P〈 0.05), but the HDL-C level had no significant difference (P〉 0. 05), and between the subsets of experiment there was no statistically significant difference(P~ 0. 05). (2)Comparing FINS between control group and MAU normal group, there was no significant difference(P〉0.05), but MAU positive group were significantly higher than that of control group(P〈0.05), between the various sub-groups in experiment group there was no statistical significant difference(P〉 0.05). (3)The HOMA-IR levels of the experimental group were higher than those in control group(P〉0.05), between the subsets of experiment there was no statistically significant difference(P:〉0. 05). (4)The level of plasma PAI-1 of Experimental group was higher than the control group(P〈0.01),MAU positive group was higher than the MAU normal group(P〈0.01). (5)The result of PAI-1 were linear correlation with the result of Alb/Cr, HOMA-IR,FBG,HbAlc,BMI,TC,TG(P〈0.01 or P〈0. 05 ) ;Multiple stepwise regression analysis showed that Alb/Cr, H bAlc levels were significant factors that affect the fasting plasma PAI-1 levels,which could explain HbAlc fasting plasma
出处 《中国冶金工业医学杂志》 2012年第3期249-252,共4页 Chinese Medical Journal of Metallurgical industry
关键词 2型糖尿病 纤溶酶原激活物抑制剂-1 微量白蛋白尿 Type 2 diabetes mellitus Plasminogen activator inhibitor-1 Microalbuminuria
  • 相关文献

参考文献8

  • 1Giltay E J, Elber JMH, Fibrt GL, et al. Visceral fat accumulation is an important determinate of PAI-1levels in young, nonbese and woman modulation by cross-sex hormone administration[J]. Thromb Vase Biol, 1998,18(11):1716-1722. 被引量:1
  • 2Herlihy OM, Barrow BA, Grant PJ, et al. Hyperglycaemic siblings of Type II ( non-insulin- dependent) diabetic patients have increased PAI 1, central obesity and insulin resistance compared with their paired normoglyeaemic sibling [J]. Diabetologia, 2002,45(5) : 635-641. 被引量:1
  • 3Festa A D, Agostino R Jr, Tracy RP, et al. Elevated levels of acute~phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes:the insulin resistance atherosclerosis study[J]. Diabetes, 2002,51 (4) : 1131-1137. 被引量:1
  • 4He G, Bruun JM, Lihn AS, et al. Stimulation of PAI-1 and adipokines by glucose in human adipose tissue in vitro [J]. Bioehem Biophys Res Commun, 2003,310: 878-883. 被引量:1
  • 5Zhu Y, Farreh PM, Fay WP. Plasminogen activator inhibitor-1 enhances enhances neointima formation after oxidative vascular injury in atheroselerosis pronemice[J]. Circulation, 2001, 103 (25) :3105. 被引量:1
  • 6赵玲,黄春林,卢富华.糖毒清对糖尿病肾病大鼠肾组织TGF-β1mRNA及PAI-1表达的影响[J].广东医学,2006,27(2):188-189. 被引量:6
  • 7刘亚军,严钟德,庞久高.纤溶酶原激活物抑制物1与糖尿病肾病[J].中国糖尿病杂志,2002,10(6):373-375. 被引量:4
  • 8闻杰,陆志强,殳雪怡,吴丹,张忆文,滕香宇,谭燕,杨永年.2型糖尿病微量白蛋白尿的临床诊断意义[J].上海医学,2008,31(4):249-253. 被引量:9

二级参考文献20

  • 1卢富华,黄春林,赵玲,侯海晶,王利胜.毒乃清颗粒对糖尿病肾病肾功能不全大鼠的影响[J].中国中医药信息杂志,2005,12(1):28-30. 被引量:10
  • 2WOLF G.Link between angiotensin Ⅱ and TGF-β in the kidney[J].Electrolyte Metab,1998,25:174. 被引量:1
  • 3LOSKUTOFF D J,SAWDEY M,KEETON M,et al.Regulation of PAI-1 gene expression in vivo[J].Thromb Haemost,1993,70:135-137. 被引量:1
  • 4Hirano T, Kashiwazaki K, Moritomo Y, et al. Albuminuria is directly associated with increased plasma PAl-1 and factor Ⅶ level in NIDDM patients. Diabetes Res Clin Pract, 1997,36 : 11-18. 被引量:1
  • 5Kruszynska YT, Yu JG, Olefsky JM, et al. Effects troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects. Diabetes, 2000,49 : 633-639. 被引量:1
  • 6Mogensen CE, Keane WF, Bennett PH, et al. Prevention of diabetic renal disease with special reference to microalbuminuria.Lancet, 1995,346: 1080-1084. 被引量:1
  • 7Hong CY, Chia KS. Markers of diabetic nephropathy. J Diabetic Comp,1998,12:43-60. 被引量:1
  • 8Torffvit O, Agardh CD, Thulin T, et al. A study of Tamm-Horsfall protein in hypertensive patients and type 1 diabetic patients. Scand J Urol Nephrol,1999,33:187-191. 被引量:1
  • 9Feldt-Rasmussen B. Microalbuminuria, endothelial dysfunction and cardiovascular risk. Diabetes Metab, 2000, 26 Suppl 4: 64-66. 被引量:1
  • 10Sasaki A, Oikawa S, Toyota T. Microalbuminuria is closely related to diabetic macroangiopathy. Diabetes Res Clin Pract, 1999,44: 35-40. 被引量:1

共引文献15

同被引文献13

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部